PNC FINANCIAL SERVICES GROUP, INC. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$278,000
+34.3%
11,956
-8.4%
0.00%
Q1 2018$207,000
-8.4%
13,058
+20.5%
0.00%
Q4 2017$226,000
+85.2%
10,839
+27.4%
0.00%
Q3 2017$122,000
-21.8%
8,506
-4.7%
0.00%
Q2 2017$156,000
+28.9%
8,928
-18.6%
0.00%
Q1 2017$121,000
+1.7%
10,965
+33.7%
0.00%
Q4 2016$119,000
-30.4%
8,202
+17.7%
0.00%
Q3 2016$171,000
+18.8%
6,966
-2.1%
0.00%
Q2 2016$144,000
-95.3%
7,118
-93.9%
0.00%
-100.0%
Q1 2016$3,049,000
-76.5%
115,876
-9.3%
0.00%
-73.3%
Q4 2015$12,982,000
+11.3%
127,715
+95.4%
0.02%
+7.1%
Q3 2015$11,659,000
-18.6%
65,354
+1.4%
0.01%
-12.5%
Q2 2015$14,316,000
+0.7%
64,447
-10.0%
0.02%0.0%
Q1 2015$14,219,000
+32.9%
71,593
-4.2%
0.02%
+33.3%
Q4 2014$10,700,000
+6.0%
74,760
-2.8%
0.01%0.0%
Q3 2014$10,095,000
+2.1%
76,940
-1.8%
0.01%
-7.7%
Q2 2014$9,883,000
+210.4%
78,368
+224.4%
0.01%
+225.0%
Q1 2014$3,184,000
+16.4%
24,155
+3.7%
0.00%0.0%
Q4 2013$2,735,000
+11.8%
23,296
-0.7%
0.00%0.0%
Q3 2013$2,447,000
+26.7%
23,450
+4.4%
0.00%
+33.3%
Q2 2013$1,932,00022,4540.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q1 2018
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders